These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16364641)

  • 1. The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1217-20. PubMed ID: 16364641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    FEBS Lett; 2005 Dec; 579(30):6726-32. PubMed ID: 16310776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple allosteric sites on muscarinic receptors.
    Birdsall NJ; Lazareno S; Popham A; Saldanha J
    Life Sci; 2001 Apr; 68(22-23):2517-24. PubMed ID: 11392621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.
    Han C; Chatterjee A; Noetzel MJ; Panarese JD; Smith E; Chase P; Hodder P; Niswender C; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Jan; 25(2):384-8. PubMed ID: 25435150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and optimization of selective azaindole amide M1 positive allosteric modulators.
    Davoren JE; O'Neil SV; Anderson DP; Brodney MA; Chenard L; Dlugolenski K; Edgerton JR; Green M; Garnsey M; Grimwood S; Harris AR; Kauffman GW; LaChapelle E; Lazzaro JT; Lee CW; Lotarski SM; Nason DM; Obach RS; Reinhart V; Salomon-Ferrer R; Steyn SJ; Webb D; Yan J; Zhang L
    Bioorg Med Chem Lett; 2016 Jan; 26(2):650-655. PubMed ID: 26631313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor.
    Flohr A; Hutter R; Mueller B; Bohnert C; Pellisson M; Schaffhauser H
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5415-5419. PubMed ID: 29146472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.
    Hollingsworth SA; Kelly B; Valant C; Michaelis JA; Mastromihalis O; Thompson G; Venkatakrishnan AJ; Hertig S; Scammells PJ; Sexton PM; Felder CC; Christopoulos A; Dror RO
    Nat Commun; 2019 Jul; 10(1):3289. PubMed ID: 31337749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of analogues of the M1 allosteric agonist TBPB. Part I: Exploration of alternative benzyl and privileged structure moieties.
    Bridges TM; Brady AE; Kennedy JP; Daniels RN; Miller NR; Kim K; Breininger ML; Gentry PR; Brogan JT; Jones CK; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5439-42. PubMed ID: 18805692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptor.
    Davie BJ; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    ACS Chem Neurosci; 2014 Oct; 5(10):902-7. PubMed ID: 25188871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
    Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M
    Jörg M; Khajehali E; van der Westhuizen ET; C Choy KH; Shackleford DM; Tobin AB; Sexton PM; Valant C; Capuano B; Christopoulos A; Scammells PJ
    ChemMedChem; 2021 Jan; 16(1):216-233. PubMed ID: 32851779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
    Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
    Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids with M1 muscarinic acetylcholine receptor binding activity.
    Swaminathan M; Chee CF; Chin SP; Buckle MJ; Rahman NA; Doughty SW; Chung LY
    Molecules; 2014 Jun; 19(7):8933-48. PubMed ID: 24979399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.